Every year, more than 100,000 people are treated for heat injury in the U.S., a number that's been rising as the world ...

Heart disease is closely linked with obesity. Excess weight mainly accounts for the surge in deaths from cardiovascular ...

The conversation surrounding health care reform has intensified in recent years, revealing deep divides in how we view personal responsibility, government intervention and public health ...

Advances in medical treatment for cardiovascular disease, a leading cause of death in the U.S., have helped patients live longer. But a new report finds that risk factors that lead to heart disease ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Someone dies of heart disease about every 34 seconds in the US, according to a new report, confirming the often preventable condition as the nation's leading cause of death.

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

A 'remarkable' diet adapted from the daily routine of people in remote parts of Papua New Guinea has been found to ...

A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...